HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICCVAM, NICEATM Request Info On Non-Animal Testing; June Deadlines Set

This article was originally published in The Rose Sheet

Executive Summary

Input is requested on the use of topical anesthetics and systemic analgesics during in vivo eye irritation testing and on the murine local lymph node assay for predicting sensitization potential as part of a federal initiative to reduce, refine and replace toxicological tests performed on animals

You may also be interested in...



ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing

Two federal agencies charged with reducing, refining and replacing the use of animals in U.S. toxicology testing have released a draft plan that, beginning in 2008, will guide their efforts over the next five years

SACATM Examines Federal Five-Year Plan For Non-Animal Toxicity Research

The Scientific Advisory Committee on Alternative Toxicological Methods considered a proposed federal research priority ranking for the development of non-animal-based approaches to toxicity testing at a Nov. 30 meeting in Research Triangle Park, N.C

No To Grapefruit Mask? Natural Player Yes To, Inc. Issues Recall Following ‘Chemical Burn’ Reports

Yes To is investigating reports – including posts on leading social media platforms – regarding irritation and redness experienced by children and other users of its Yes To Grapefruit Glow-Boosting Unicorn Paper Mask. In the meantime, the company is recalling the product voluntarily.

UsernamePublicRestriction

Register

RS014738

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel